Physician profile
Patrick W Logan
NPI 1790896066
$931.49
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $16.09 · 2021: $47.75 · 2022: $308 · 2023: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $155.41 | 2019-2023 | |
| Amgen INC. | $125.10 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $118.82 | 2021-2023 | |
| Glaxosmithkline, LLC. | $69.60 | 2019-2023 | Bexsero, Shingrix, Arexvy |
| Lilly USA, LLC | $56.26 | 2023 | Mounjaro |
| Vbi Vaccine (Delaware) INC. | $55.85 | 2022 | |
| Novo Nordisk INC | $50.43 | 2019 | |
| Sanofi Pasteur INC. | $45.00 | 2019 | |
| Abbott Laboratories | $42.56 | 2023 | Proclaim, Eterna |
| Abbvie INC. | $39.64 | 2019 | |
| Hikma Pharmaceuticals USA | $35.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.38 | 2022 | |
| Medtronic, INC. | $24.53 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.12 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.23 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.95 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.